Oral session 5

  • Location:
    Lindenbergzaal
  • Chairs:
     K. Junker, Homburg (DE)
     E. Oosterwijk, Nijmegen (NL)
Predicting clinical response based on ex vivo drug treatment in renal cell carcinoma using kinase activity profiling
 J.C. Oosterwijk-Wakka, Beuningen (NL)
Neuropilin 2 deletion enhances detrusor contractility under conditions of chronic bladder obstruction
 R.M. Adam, Boston (US)
Salinomycin, a novel cancer stem cell- targeting compound in bladder carcinoma?
 G. Van Der Horst, Leiden (NL)